Skip to content
  • News & Events
  • Resources
  • Customer Account ↗
  • United States
    • Worldwide
    • French
    • Spanish
  • About SUDOSCAN
  • FAQ
  • Patients Information
Request a demo
Contact us
  • SUDOSCAN
    • About SUDOSCAN
    • Discover Sudocloud: Your Remote Patient Monitoring Revolution
    • FAQ
    • Patients Information
  • THERAPEUTIC AREAS
    TERMS (3)
    Diabetes

    SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.

    Picto-Neurology
    Neurology

    Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.

    Picto-Oncology
    Oncology

    SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).

    Nephrology

    SUDOSCAN has demonstrated its clinical utility in Nephrology.

    Picto-Follow-up
    Follow-up

    A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.

    Diabetes Risk

    Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score

    • SUDOSCAN and Diabetes
    • SUDOSCAN in Neurology
    • SUDOSCAN in Oncology
    • SUDOSCAN in Nephrology
    • Follow-up with SUDOSCAN
    • EZSCAN
  • SCIENCE & RESEARCH
    • SUDOSCAN Publications
    • Scientific news
    • Join Clinical Research
    • Subscribe to our Scientific News
  • WHO WE ARE
    • About Impeto Medical
    • Impeto Medical in the World
Contact us
Order Supplies ↗

Scientific news

Scientific news

Home » SCIENCE & RESEARCH » Scientific news
Scientific newsSebastien2020-12-23T13:48:45+00:00
  • EventsEventsWebinar

    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    July 29, 2026
  • Diabetes

    The use of SUDOSCAN® to screen for diabetic neuropathy in individuals with type 2 diabetes and prediabetes

    The use of SUDOSCAN® to screen for diabetic neuropathy in [...]

    Read Article
  • Events / Events / Webinar

    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    Read Article
  • Events / Events / Webinar

    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    Read Article
  • Events / Webinar

    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    Read Article
12Next

Subscribe to receive our scientific news

Name(Required)
Consent(Required)
  • Events,Events,Webinar
    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    October 4, 2026

  • Events,Webinar
    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    October 4, 2026

  • Events,Events
    Sudoscan to Participate in the 4th Multidisciplinary French-Speaking Conference on Amyloidosis

    October 4, 2026

About Sudoscan

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company’s corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia

For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark

Sudoscan in the world
  • About SUDOSCAN
  • FAQ
  • Patients Information
More information
  • About SUDOSCAN
  • FAQ
  • Patients Information
Sudoscan Shop
  • Customer Account ↗
  • Order Supplies ↗
Sudoscan Technology
  • About SUDOSCAN
  • FAQ
  • Patients Information
Contact info
  • US TERRITORIES:

    SUDOSCAN Inc.
    8525 Gibbs Dr. Suite 304
    San Diego, CA 92123

  • Phone: 858-450-2800
  • INTERNATIONAL:

    Impeto Medical
    2 Rue Maurice Hartmann,
    92130 Issy-les-Moulineaux,
    France

  • Phone: +33 (0)7 87 20 32 03

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

Page load link

Remote Patient Monitoring Revolution

Discover Sudocloud

Seamlessly connect, retrieve, and manage patient data with our secure and efficient cloud-based platform.

Read more about SUDOCLOUD

Innovations in Autonomic Function Testing

  • About SUDOSCAN
  • FAQ
  • Patients Information
Contact Info

France HEADQUATERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux

Phone: +33 (0)7 87 20 32 03

Discover SudoscanDiscover Sudoscan
Go to Top